Indian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...

Indian stock markets closed higher on Tuesday. Sensex and Nifty saw a significant rally over three sessions. This surge was driven by optim...

India's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...

India's IPO market saw a slowdown in 2026 following a robust 2025. However, activity is picking up with several companies set to launch pub...

Global markets are cautiously optimistic about a potential US-Iran agreement easing geopolitical risks and crude oil volatility. However, I...

A US-Iran peace deal is expected to ease oil supply risks, pushing crude prices lower. Nomura sees OMCs, CGDs, and Petronet LNG as key bene...

Sebi has introduced a new framework for ETFs, replacing fixed price bands with dynamic limits and revising base price calculations. The cha...

Monarch Networth Capital expects Nifty to reach 27,000-28,000 in 2026, driven by earnings recovery, capex growth and lower interest rates. ...

Suzlon Energy shares rose 3% after management unveiled an ambitious FY31 growth roadmap at its Investor Day. The company plans to evolve fr...

India's Finance Minister Nirmala Sitharaman highlighted significant economic challenges. These include fluctuating foreign exchange and cru...

Vedanta’s four demerged entities debuted on exchanges, with brokerages highlighting aluminium as the most attractive segment. Analysts cite...

Brokerages remain selective on India's energy sector, favouring companies with strong growth drivers and attractive valuations. Morgan Stan...

Indian equity markets concluded a volatile week on a strong note, breaking a two-week losing streak. This surge was fueled by improving glo...

Markets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...

Foreign investors have significantly reduced holdings in many Nifty companies since September 2024. This has impacted top blue-chip stocks,...

Citi Research lowered its Nifty target due to rising earnings risks linked to geopolitical tensions and other macro concerns. However, it r...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...